L1CAM and ovarian carcinoma: Moreover, L1CAM in combination with CD133 characterizes a new specific ovarian cancer stem cell (CSC) population, displaying increased radioresistance, enhanced spherogenic and clonogenic property, self‐renewal capacity and superior tumour growth in nude mice.38